<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyCompanySummaryOutput xmlns:ns2="local" id="14190" name="AstraZeneca plc"><Parent>AstraZeneca plc</Parent><CountDrugsInDevelopment>276</CountDrugsInDevelopment><ActiveTAs><ActiveTA id="651">Cancer</ActiveTA><ActiveTA id="31">Asthma</ActiveTA><ActiveTA id="1262">Non-small-cell lung cancer</ActiveTA><ActiveTA id="1185">Chronic obstructive pulmonary disease</ActiveTA><ActiveTA id="49">Breast tumor</ActiveTA><ActiveTA id="3713">Advanced solid tumor</ActiveTA><ActiveTA id="799">Ovary tumor</ActiveTA><ActiveTA id="837">Non-insulin dependent diabetes</ActiveTA><ActiveTA id="3657">Metastatic breast cancer</ActiveTA><ActiveTA id="178">Hypertension</ActiveTA></ActiveTAs><Website>https://www.astrazeneca.com/Home</Website></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyCompanySummaryOutput>